Skip to main content
. 2022 Dec 13;35(6):321–332. doi: 10.1089/jamp.2022.0005

FIG. 2.

FIG. 2.

Diagram of the INP104 product. Delivery of DHE mesylate using POD technology (INP104) involves manual actuation by the user (squeezing of the surfaces noted by the white arrows), which after priming the device draws up a precise volume of DHE mesylate (red arrows) from the liquid drug reservoir to the dose chamber. The propellant, HFA-134a (blue arrows), is directed from the propellant canister, and its release creates a pressure as the gas expands, channeling DHE mesylate through the nozzle and expelling the drug from the device and to the UNS. Subsequently, the HFA-134a propellant pushes the released DHE mesylate deeper into the UNS in a second phase of deposition. DHE, dihydroergotamine; HFA, hydrofluoroalkane; POD, Precision Olfactory Delivery.